Market revenue in 2021 | USD 242.2 million |
Market revenue in 2028 | USD 834.6 million |
Growth rate | 19.3% (CAGR from 2021 to 2028) |
Largest segment | Left ventricular assist devices |
Fastest growing segment | Total Artificial Heart (TAH) |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Left ventricular assist devices, Right ventricular assist devices, Bi-ventricular assist devices, Total Artificial Heart (TAH) |
Key market players worldwide | Johnson & Johnson, Medtronic PLC, Abbott Laboratories, Cardio Diagnostics Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ventricular assist device market will help companies and investors design strategic landscapes.
Left ventricular assist devices was the largest segment with a revenue share of 83.4% in 2021. Horizon Databook has segmented the Asia Pacific ventricular assist device market based on left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, total artificial heart (tah) covering the revenue growth of each sub-segment from 2018 to 2028.
Asia Pacific is expected to witness high GDP growth over the coming years, mainly led by growth in India, China, Singapore, Indonesia, and Australia. Increase in government initiatives undertaken to encourage healthcare providers and other healthcare organizations to adopt technologically advanced medical devices & systems is a key factor indicated to drive ventricular assist device market.
In terms of technology adoption in APAC region, Singapore, Japan, Australia, and South Korea have been adopting technology on a large scale in the healthcare sector whereas China, Thailand, India, and Malaysia are the emerging markets.
There are several MNC and domestic pharmaceutical and medical device companies. This region has a significant difference in healthcare infrastructure and reimbursement scenario as compared to Europe and North America.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific ventricular assist device market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific ventricular assist device market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account